ince the early 1980s, I have done extensive research, case writing and consulting in the pharmaceutical and biotechnology industry. Through this work, I became deeply interested in the fundamental question of how science moves from the lab to the market. I am particularly intrigued by the convergence between the worlds of science and business and the implications for both society and companies.
Why has the biotechnology industry failed to perform up to expectations – despite all its promise? This question is answered in “Science Business” by providing an incisive critique of the industry. Not only does it reveal the underlying causes of biotech's problems; it offers the most sophisticated analysis yet on how the industry works.
Forget the Science. These Investors Think They Can Pick Biotech Winners by Algorithm
Neurodiversity as a Competitive Advantage
Why You Should Make Time for Self-Reflection (Even If You Hate Doing It)
One Way to Improve Job Performance: Reflect on Your Work
Does America Need Manufacturing?
Institutionalized Entrepreneurship: Flagship Pioneering
Harvard Business School Case no. 718-8484
This case examines an unusual model for innovation and entrepreneurship.